BIOMAT Database Logo BIOMAT Database Logo

Bifidenone: Structure-Activity Relationship and Advanced Preclinical Candidate. 2018

Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Albany Molecular Research Inc. , 1001 Main Street , Buffalo , New York 14203 , United States.

Bifidenone is a novel natural tubulin polymerization inhibitor that exhibits antiproliferative activity against a range of human cancer cell lines, making it an attractive candidate for development. A synthetic route was previously developed to alleviate supply constraints arising from its isolation in microgram quantities from a Gabonese tree. Using that previously published route, we present here 42 analogues that were synthesized to examine the structure-activity relationship of bifidenone derivatives. In addition to in vitro cytotoxicity data, data from murine xenograft and pharmacokinetic studies were used to evaluate the analogues. Compounds 45b and 46b were found to demonstrate promising efficacy in murine xenograft experiments, and 46b had significantly more potent in vitro antiproliferative activity against taxane-resistant cell lines compared to that of paclitaxel.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055503 Protein Multimerization The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS. Protein Dimerization,Protein Heteromultimerizaton,Protein Multimer Assembly,Protein Trimerization,Assembly, Protein Multimer,Dimerization, Protein,Heteromultimerizaton, Protein,Heteromultimerizatons, Protein,Multimer Assembly, Protein,Multimerization, Protein,Trimerization, Protein

Related Publications

Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Structure-activity relationship of anticancer drug candidate quinones.
January 2024, Turkish journal of chemistry,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Design, structure-activity relationship, and in vivo characterization of the development candidate NVP-HSP990.
November 2014, Journal of medicinal chemistry,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Structure-activity relationship in advanced glycation end products formation inhibitory activity of phlorotannins.
August 2022, Bioscience, biotechnology, and biochemistry,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drug.
June 2009, BMC research notes,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Preclinical pharmacology and structure-activity studies of epothilones.
January 2009, Fortschritte der Chemie organischer Naturstoffe = Progress in the chemistry of organic natural products. Progres dans la chimie des substances organiques naturelles,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
January 2022, Bioorganic & medicinal chemistry,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
The structure-activity relationship of aromatic compounds in advanced oxidation processes：a review.
June 2022, Chemosphere,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Structure-activity relationship of procyanidins on advanced glycation end products formation and corresponding mechanisms.
January 2019, Food chemistry,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
[Structure-activity relationship analysis].
April 2004, Gan to kagaku ryoho. Cancer & chemotherapy,
Zhongping Huang, and Russell B Williams, and Steven M Martin, and Julie A Lawrence, and Vanessa L Norman, and Mark O'Neil-Johnson, and Jim Harding, and John E Mangette, and Shuang Liu, and Peter R Guzzo, and Courtney M Starks, and Gary R Eldridge
Dovitinib (CHIR258, TKI258): structure, development and preclinical and clinical activity.
January 2015, Future oncology (London, England),
Copied contents to your clipboard!